OX40 Receptor Agonist Market Projected to Discern Stable Expansion During 2020-2030 Oct 2020
Report Id : REP-GB-12571 Status : Ongoing Category : Healthcare, Pharmaceuticals & Medical Devices @futuremarketins I /company/future-market-insights
www.futuremarketinsights.com I
Š 2019 Future Market Insights, AllI Rights/company/future-market-insights Reserved www.futuremarketinsights.com I @futuremarketins
About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client.
Research Capabilities
Customized Research Syndicated Research
Customized Research Syndicated Research Investment Research Social Media Research
Sector Coverage
Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment
Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas
Subscription Information
For detailed subscription information please contact
Investment Research
Hari. T (Sr. Manager - Global Business Development)
Social Media Research
Email: hari.t@futuremarketinsights.com
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
www.futuremarketinsights.com I
@futuremarketins I
/company/future-market-insights
© 2019 Future Market Insights, All Rights Reserved
2
Research Methodology (1/2) Systematic Research Approach 1 Market profiling
2 Formulating discussion guide
3 Developing list of respondents
4 Data collection
5
Data validation
6
Data analysis
Insights
7
In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. FMI formulates a detailed discussion guide to conduct expert and industry interviews FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts FMI conducts interviews with industry experts, industry players, distributors and retailers Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry FMI delivers industry insights and information in the required format (PDF)
Data Collection
Research & Intelligence
Data Filter & Analysis
Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain
Actionable Insights
A Primary Research
SOLUTION
Market participants
Key strengths
Product portfolio
Mapping as per value chain
Key focus segments
Key industry experts
Channel study
B
Developments
Desk Research
Market dynamics
Products
Conclusions
C Company Analysis
Primary Research #
Business Solution
Linkedin Zoominfo Salesforce Avention
Secondary Research #
Company websites Company annual reports White papers Financial reports
Paid Publications#
Factiva GBI Genios Meltwater
# includes sources of databases
www.futuremarketinsights.com I
@futuremarketins I
/company/future-market-insights
© 2019 Future Market Insights, All Rights Reserved
3
OX40 Receptor Agonist Market Analysis Market Overview OX40 receptor agonists bind to the receptors of tumour necrosis factor, OX40. OX40 agonists are used for cancers and autoimmune disease treatment. OX40 receptor agonists are the antibody that binds to the OX40 receptors to generate the same or boosted response of OX40 ligands including T-cell activation and co-stimulations, also in combination with checkpoint immunotherapies, radiotherapy and surgical resections. According to the American Institute of Cancer Research Fund, there are over 18 million cancer cases worldwide, 9.5 million in men and 8.5 million in women, with lung and breast cancer, are the most prevalent. Overall 23.5 million people (>7% of total population) suffer from autoimmune diseases in U.S, stated by National Institutes of Health. OX40 receptor agonists or anti-OX40 antibodies promote the expansion and proliferation of CD4 helper cells and CD8 killer cells.
The OX40 receptor agonist intratumor injection prolongs the tumour-free survival capacity. Several pre-clinical studies have resulted in positive outcomes of OX40 receptor agonists on cancers.
www.futuremarketinsights.com I
@futuremarketins I
/company/future-market-insights
Š 2019 Future Market Insights, All Rights Reserved
4
OX40 Receptor Agonist Market Analysis The anti-cancer effects of OX40 receptor agonists include both expansion and depletion of regulatory T cell, FoxP3+ regulatory T-cells depending upon the cytokine environment and signal stimulations.
The global market of OX40 receptor agonists market is poised to grow lucratively with the escalating research, successful clinical trials and rising cancer cases. Coronavirus has boosted the global OX40 receptor agonists market with elevated research, wherein the immunomodulatory nature of OX40 receptor agonist is utilized for medication of Coronavirus, by generating CD8+T cells in the mucosal surface. OX40 Receptor Agonist Market: Drivers and Restraints
The global OX40 receptor agonists market drivers include the increasing cancer and autoimmune diseases, escalating immunotherapy research, global healthcare infrastructure, positive clinical trials and pipeline drugs. OX40 receptor agonists are actively dwelled by the research institutes and pharmaceutical companies for cancer immunotherapies, inflammatory diseases and autoimmune diseases. www.futuremarketinsights.com I
@futuremarketins I
/company/future-market-insights
Š 2019 Future Market Insights, All Rights Reserved
5
OX40 Receptor Agonist Market Analysis Drug manufactures are working with the key perspective of developing novel OX40 receptor agonists with better receptor targeting, efficacy, safety and lesser adverse reactions. However, the global OX40 receptor agonists market is constrained by conflicting outcomes and controversies among in vivo and in vitro results of OX40 receptor agonists. Further ancillary studies are needed for understanding the mechanism of OX40 mAbs based treatments. OX40 receptor agonists possess adverse reaction including immunosuppressive effects with increased MDSC cells and TH2 cytokines. Although the overall global OX40 receptor agonists market is expected to revamp in future for cancer and autoimmune disease therapies, due to the successful clinical trials and advancing research. This will be beneficial for better understanding of OX40 mAbs for developing safer and effective OX40 receptor agonists. The OX40 receptor agonists are emerging therapy for highrisk neck and head cancers with adjuvants, sarcoma, liver metastasectomy in colon cancer and ovarian cancer debulking. www.futuremarketinsights.com I
@futuremarketins I
/company/future-market-insights
Š 2019 Future Market Insights, All Rights Reserved
6
OX40 Receptor Agonist Market Analysis OX40 Receptor Agonist Market: Segmentation The global OX40 receptor agonists market is segmented into drugs, molecule types, route of administration, applications and regions. Drugs:
• Axitinib • Tavolixizumab • Pogalizumab
Molecule type: • Fully human IgG2 agonist Ab • Humanised IgG1 agonist mAb
• Fully human IgG1 agonist mAb
www.futuremarketinsights.com I
@futuremarketins I
/company/future-market-insights
© 2019 Future Market Insights, All Rights Reserved
7
OX40 Receptor Agonist Market Analysis Administration type: • Intratumoral Injection
• Intraperitoneal Injection Applications: • Cancers • Myasthenia Gravis • Psoriasis
Click here to Order a free sample For more insights on the Wound Irrigation System Market, you can request a report sample with full TOC www.futuremarketinsights.com I
@futuremarketins I
/company/future-market-insights
© 2019 Future Market Insights, All Rights Reserved
8
To know more about us, please visit our website:
www.futuremarketinsights.com For sales queries or new topics email us on:
sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com
Thank You Future Market Insights Global & Consulting Private Limited (FMI) www.futuremarketinsights.com I
@futuremarketins I
/company/future-market-insights
Š 2019 Future Market Insights, All Rights Reserved
9